Gene Query: NELFA

Dataset Description Geneva Score
METTL3 promotes translation in human cancer cells 24.2
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 15.22
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 13.39
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 12.41
CD73 knockdown effect in pancreatic cancer cell lines 11.06
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 11.04
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.98
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 10.81
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 10.39
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.32
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.32
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 10.15
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 10.15
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 9.75
Human HAP1 cells before and after nutrient deprivation 9.75
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.63
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 9.22
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 9.08
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 8.78
Effect of PRDM11 depletion in U2932 cells 8.45
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.42
SNHG5 siRNA knock down in HCT116 cells 8.38
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.12
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.08
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.98
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.9
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 7.78
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 7.62
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.45
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.37
ETV7 and interferon response 7.37
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 7.28
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.99
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.9
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 6.88
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.87
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.74
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 6.73
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 6.46
R430: A potent inbibitor of DNA and RNA viruses 6.46
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.38
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.38
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 6.3
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.23
RNA splicing alteration on glioblastoma and normal neural stem cells 6.1
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.8
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 5.71
The evolution of N6-methyladenosine in primates 5.7
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 5.68
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 5.66
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.65
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.59
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.55
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.44
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.39
Impact of dieldrin on transcription in Jurkat T cells 5.37
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.25
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.24
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 5.22
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.05
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.98
RNAseq Analysis in glioblastoma cells treated with Mepazine 4.94
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 4.92
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.91
AUF-1 affected genes in human skin cells 4.87
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.83
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.81
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.81
PRDM1 inhibits proliferation of human colon cancer organoids 4.81
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.81
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 4.7
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 4.7
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.67
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.67
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.65
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.64
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 4.61
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 4.61
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.57
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 4.56
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 4.55
N6-methyladenine DNA Modification in Glioblastoma 4.52
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.52
Seletive inhibition of CDK9 in DLBCL cell lines 4.5
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.46
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.43
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 4.41
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.36
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 4.35
RNAseq Study in CC-671 Treated Cal-51 Cells 4.31
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 4.23
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 4.21
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.18
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.16
Tracking of dCas9-methyltransferase footprints 4.1
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.08
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.08
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 4.08
Global analysis of enhancer targets: Mosaic-seq 4.04
Differentiation enhances Zika virus infection in neuronal brain cells 4.02
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 4.01
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 4.0
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.99
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.99
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.99
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 3.96
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.94
High-throughput sequencing of pluripotent cells 3.92
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 3.91
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.88
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.87
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.85
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.82
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.74
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.74
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.72
Transcriptome analysis of SKI knock-out in HL60 cells 3.72
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 3.69
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 3.69
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.68
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.67
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.67
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.66
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.66
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.65
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 3.64
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 3.64
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 3.63
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.63
Transcriptomic analysis of LSD1 3.62
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.61
High-Throughput Kinetic Analysis of Fractional Killing 3.58
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.49
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 3.48
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 3.48
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 3.46
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 3.46
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.43
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.43
RNA-seq analysis of control and Myc-induced U2OS cells 3.42
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.41
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 3.37
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 3.35
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.27
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.25
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.24
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 3.23
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 3.22
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.21
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.21
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.21
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 3.2
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 3.19
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 3.18
Gene expression in GBM with Cav3.2 inhibition 3.17
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 3.16
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 3.16
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.16
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.14
K562 polyA RNA-Seq 3.14
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.12
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 3.1
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 3.09
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 3.09
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.08
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.06
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 3.06
The effect of Abl kinases on non-small cell carcinoma global transcriptome 3.06
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.05
Gene expression profiling of leukemia cells following asparagine depletion 3.04
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.02
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.01
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.0
Gene expression profile in breast cancer cell lines using RNA sequencing 2.99
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.98
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 2.97
Differential gene expression of human melanoma cells [RNA-seq] 2.96
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 2.96
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 2.96
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 2.94
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.91
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.91
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.9
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.9
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.9
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.88
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 2.87
KLF6-dependent transcription in renal cancer cells 2.87
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 2.87
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.85
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 2.85
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 2.85
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.83
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.83
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.82
Differential gene expression profiles in imatinib-resistant cell lines 2.81
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.8
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.8
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.8
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.8
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.79
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.79
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.77
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 2.77
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 2.76
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.76
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.75
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.72
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.72
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 2.71
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 2.71
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.68
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 2.66
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.65
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 2.64
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 2.64
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 2.62
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 2.6
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.58
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.53
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.53
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.53
RNA polymerase in pre-B-ALL cell lines 2.52
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.52
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.5
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.49
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.46
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.46
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.46
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.46
Chromatin-informed inference of transcriptional programs in gynecologic cancers 2.43
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 2.43
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.42
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.42
RNA-seq analysis of BAP1-depleted uveal melanoma cells 2.41
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.4
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 2.39
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 2.38
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.36
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 2.34
Hepatitis C virus functionally sequesters miR-122 2.33
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.33
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 2.31
Functional role of CPPED1 in trophoblasts. 2.27
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.27
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 2.27
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.26
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.26
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 2.26
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.25
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.24
Biological effect of chronic mistranslation in mammalian cells 2.23
Identifying the molecular mode of action of itraconazole in colorectal cancer 2.21
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.18
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.17
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.17
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.15
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.15
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 2.14
Oncogenic roles of ARID5B in T-ALL 2.14
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.12
Comparative Analysis of Cas9 Activators Across Multiple Species 2.11
Illumina Total RNA-seq in HeLa 2.11
Global analyses of the effect of different cellular contexts on microRNA targeting 2.1
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 2.1
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 2.1
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.1
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.09
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.08
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.08
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.07
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.07
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.06
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.04
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.04
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.04
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.04
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.04
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.04
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.03
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.02
Noncoding regions are the main source of targetable tumor-specific antigens 2.01
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.01
RNA-seq analysis of differentiating human erythroblasts 2.0
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.99
Transciptomic profiling of human fetal lung samples 1.99
Effect of ILF3 on translation during homeostasis and the antiviral response 1.99
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.98
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.98
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.98
Functional significance of the HIV-1 Tat signature amino acid residues 1.97
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.97
Transcriptome sequencing of K-562 cells 1.96
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.96
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.94
Dysregulated immune system networks in war veterans with PTSD 1.94
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.94
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.94
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.9
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.9
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.86
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 1.86
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.86
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.84
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.81
Analysis of transcriptional regulation by Myt1 and Myt1l 1.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.8
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.8
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 1.77
Lineage specific differentiation is influenced by state of human pluripotency 1.77
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.77
EWSR1 influences alternative splicing through direct and indirect mechanisms 1.76
Gene expression analysis upon mtDNA depletion 1.75
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.75
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.72
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.68
Co-regulation of splicing by Rbfox1 and hnRNP M 1.68
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 1.67
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.66
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.66
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.66
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.64
The transcriptome and chromatin accessbility landscape of mammalian germline 1.64
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.63
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.62
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.62
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.55
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.55
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.53
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 1.53
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.52
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.52
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 1.52
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.5
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.49
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.48
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.47
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.47
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.45
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.41
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.41
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.4
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.38
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.38
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.36
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 1.35
Transposon-based construction of strand-specific RNA-seq libraries 1.35
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.34
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 1.33
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.31
Total RNA sequencing of WT intestinal orgaonids. 1.28
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.28
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.27
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.26
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 1.25
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 1.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.24
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.24
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.24
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.24
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.23
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.23
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.2
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 1.18
FBXW7 modulates stress response by post-translational modification of HSF1 1.18
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.18
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.17
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.17
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.17
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.15
Ectoderm specification of H1 human embryonic stem cells 1.15
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.15
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.14
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.12
A transcriptome-wide divergence in protein translation scales with LIN28B expression 1.12
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.11
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.1
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 1.07
Role of FGFR1 in neuronal devlopment 1.06
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.04
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.02
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.02
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.02
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.99
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.96
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.96
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.96
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.95
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.94
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.94
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.92
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.91
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.9
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.89
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.88
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.87
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.86
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 0.85
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.85
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.85
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.82
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.82
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.82
Gene expression activation in CLL mediated by MSCs contact 0.8
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.8
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.76
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.76
Energy Metabolism during Anchorage-Independence 0.75
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.73
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.7
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.7
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.68
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.68
Discovering human diabetes-risk gene function with genetics and physiological assays 0.66
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.65
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.65
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.64
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.64
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.63
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.6
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.59
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.58
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.58
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.58
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.57
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.57
An optimization system for isolating and sequencing of single human colon cancer cells 0.56
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.56
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.54
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.52
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.52
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.48
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.47
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.47
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.46
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.46
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 0.45
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.42
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.42
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.4
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.4
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.37
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.36
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.35
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.34
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.33
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.33
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.33
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.33
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.31
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.31
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.29
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 0.29
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.28
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.28
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.28
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.27
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.27
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.25
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.25
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.25
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.23
SRSF1 role in cellular gene expression and splicing 0.22
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.22
iPSC derived motor neuron cultures from C9ORF72 carriers 0.2
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.18
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.18
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.17
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.17
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.16
The circadian transcriptional landscape in primary human mammary epithelial cells 0.16
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.16
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.16
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.16
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.16
ChIP-seq and RNA-seq from human lymphoma cell lines 0.15
RNA-seq data from human lymphoma cell lines 0.15
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.1
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.09
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.04
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.04
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.04
Function and hormonal regulation of GATA3 in human first trimester placentation 0.04
The role of m6A/m-RNA methylation in stress response regulation 0.03
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.03
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.02
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.02
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.01
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation